Second Serbia Health Project

Abstract*

The objective of the Second Health Project is to contribute to improving the efficiency and quality of the public health system of the Republic of Serbia through the strengthening of: (i) health financing, purchasing, and maintenance systems; and (ii) quality improvement systems and management of selected priority non-communicable diseases. There are four components to the project, the first component being improvement of health financing. This component... Show More

Development Objective

The PDO is to contribute to improving the efficiency and quality of the public health system of the Republic of Serbia through the strengthening of: (i) health financing, purchasing, and maintenance systems; and (ii) quality improvement systems and management of selected priority non-communicable diseases.

Key Details

Project Details

Project ID
P129539
Status
Closed
Team Leader
Ha Nguyen , Predrag Djukic
Borrower 2
Ministry of Finance

Country
Serbia
Disclosure Date
August 6, 2013
Approval Date
(as of board presentation)
February 25, 2014
Effective Date
May 8, 2015

Total Project Cost 1
US$ 40.00 million
Implementing Agency
Ministry of Health
Region
Europe and Central Asia
Fiscal Year 3
2014

Commitment Amount
US$ 40.00 million
Environmental Category
B
Last Update Date
March 28, 2024
Closing Date
December 31, 2022

Consultant Services required
Yes
Last Stage Reached
BANK APPROVED

Associated Projects
P166025

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control46%
- FY17 - Non-communicable diseases46%
FY17 - Health Systems and Policies54%
- FY17 - Health System Strengthening54%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
International Bank for Reconstruction and Development	40.00

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	40.00
IDA Commitment	N/A
IBRD + IDA Commitment	40.00

Lending Instrument
Grant Amount	N/A
Total Project Cost**	40.00

Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025

No data available.

Detailed Financial Activity as of February 28, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Aug 1, 2019	IBRD-88300	Int Charges	3,501.08
Aug 1, 2019	IBRD-83380	Int Charges	322.55
Aug 1, 2019	IBRD-83380	Int Charges	33,309.88
Aug 1, 2019	IBRD-83380	Loan Repay	1,280,367.10
Aug 15, 2019	IBRD-88300	Loan Disb	3,636,038.80
Nov 22, 2019	IBRD-83380	Loan Disb	463,066.50
Sep 13, 2019	IBRD-83380	Loan Disb	262,523.56
Dec 5, 2019	IBRD-88300	Loan Disb	1,601,261.20
Mar 2, 2020	IBRD-83380	Loan Disb	1,651,041.20
Feb 1, 2020	IBRD-88300	Int Charges	6,583.74
Feb 1, 2020	IBRD-88300	Int Charges	27,071.20
Feb 1, 2020	IBRD-83380	Int Charges	44.41
Feb 1, 2020	IBRD-83380	Int Charges	16,615.01
Feb 1, 2020	IBRD-83380	Loan Repay	1,334,209.80
Jun 29, 2020	IBRD-88300	Loan Disb	561,283.60
Aug 18, 2020	IBRD-88300	Loan Disb	1,231,682.00
Aug 1, 2020	IBRD-83380	Int Charges	19,291.49
Aug 1, 2020	IBRD-83380	Loan Repay	1,530,404.50
Aug 1, 2020	IBRD-88300	Int Charges	633.99
Aug 1, 2020	IBRD-88300	Int Charges	44.71
Aug 1, 2020	IBRD-88300	Int Charges	26,684.94
Aug 1, 2020	IBRD-88300	Int Charges	9,728.72
Feb 24, 2021	IBRD-88300	Loan Disb	201,183.38
Mar 9, 2021	IBRD-83380	Loan Disb	327,992.62
Mar 9, 2021	IBRD-83380	Loan Disb	989,663.25
Feb 1, 2021	IBRD-88300	Int Charges	25,515.03
Feb 1, 2021	IBRD-88300	Int Charges	10,130.91
Feb 1, 2021	IBRD-88300	Int Charges	132.19
Feb 1, 2021	IBRD-88300	Int Charges	3.24
Jul 22, 2021	IBRD-83380	Loan Disb	182,039.75
Feb 1, 2021	IBRD-83380	Int Charges	13,556.90
Feb 1, 2021	IBRD-83380	Loan Repay	1,560,301.00
Jun 17, 2021	IBRD-88300	Loan Disb	488,380.10
Apr 7, 2021	IBRD-83380	Loan Disb	342,369.80
Apr 7, 2021	IBRD-88300	Loan Disb	289,258.94
Sep 30, 2021	IBRD-83380	Loan Disb	472,773.78
Aug 1, 2021	IBRD-88300	Int Charges	24,050.30
Aug 1, 2021	IBRD-88300	Int Charges	4,630.98
Aug 1, 2021	IBRD-83380	Loan Repay	1,640,811.10
Jun 14, 2022	IBRD-88300	Loan Disb	949,833.44
Jun 15, 2022	IBRD-83380	Loan Disb	333,697.34
Nov 10, 2021	IBRD-83380	Loan Disb	580,926.00
Nov 10, 2021	IBRD-83380	Loan Disb	492,435.72
Nov 10, 2021	IBRD-88300	Loan Disb	245,268.61
Nov 10, 2021	IBRD-88300	Loan Disb	937,996.25
May 27, 2022	IBRD-88300	Loan Disb	1,014,128.60
May 27, 2022	IBRD-88300	Loan Disb	1,107,212.10
Mar 22, 2022	IBRD-88300	Loan Disb	243,809.36
Aug 1, 2022	IBRD-88300	Int Charges	3,409.68
Aug 1, 2022	IBRD-83380	Loan Repay	1,515,313.60
Aug 1, 2022	IBRD-88300	Int Charges	17,453.49
Feb 1, 2022	IBRD-83380	Int Charges	1,240.39
Feb 1, 2022	IBRD-83380	Loan Repay	1,666,379.20
Feb 1, 2022	IBRD-88300	Int Charges	51.90
Feb 1, 2022	IBRD-88300	Int Charges	90.32
Feb 1, 2022	IBRD-88300	Int Charges	21,820.03
Feb 1, 2022	IBRD-88300	Int Charges	6,071.10
Aug 29, 2022	IBRD-88300	Loan Disb	657,298.20
Oct 31, 2022	IBRD-88300	Loan Disb	1,207,863.00
Nov 14, 2022	IBRD-88300	Loan Disb	446,533.12
Oct 18, 2022	IBRD-83380	Loan Disb	275,182.88
Feb 1, 2023	IBRD-88300	Int Charges	246.66
Feb 1, 2023	IBRD-88300	Int Charges	14,010.53
Feb 1, 2023	IBRD-88300	Int Charges	100,081.98
Feb 10, 2023	IBRD-88300	Loan Disb	3,731,169.00
Feb 10, 2023	IBRD-88300	Loan Disb	4,848,864.00
Mar 8, 2023	IBRD-88300	Loan Disb	1,265,470.40
Feb 1, 2023	IBRD-83380	Int Charges	123,902.30
Feb 1, 2023	IBRD-83380	Loan Repay	1,660,276.20
Mar 22, 2023	IBRD-88300	Loan Disb	197,855.10
Feb 1, 2023	IBRD-88300	Int Charges	79.32
Apr 11, 2023	IBRD-88300	Loan Disb	29,945.80
Aug 1, 2023	IBRD-88300	Loan Repay	1,443,914.00
Aug 1, 2023	IBRD-83380	Int Charges	346,306.80
Aug 1, 2023	IBRD-83380	Loan Repay	1,673,917.50
Aug 1, 2023	IBRD-88300	Int Charges	947.61
Aug 1, 2023	IBRD-88300	Int Charges	473,579.66
Jun 28, 2023	IBRD-83380	Loan Disb	-11,519.98
Jun 28, 2023	IBRD-83380	Loan Disb	-12,037.54
Jun 28, 2023	IBRD-88300	Loan Disb	-44,378.64
Jun 28, 2023	IBRD-88300	Loan Disb	-330.79
Jun 28, 2023	IBRD-88300	Loan Cancel	50,110.17
Jun 28, 2023	IBRD-83380	Loan Cancel	23,557.52
Feb 1, 2024	IBRD-88300	Int Charges	-11.51
Feb 1, 2024	IBRD-88300	Int Charges	11.51
Feb 1, 2024	IBRD-83380	Int Charges	405,071.06
Feb 1, 2024	IBRD-83380	Loan Repay	1,645,360.00
Feb 1, 2024	IBRD-83380	Int Charges	75.28
Feb 1, 2024	IBRD-88300	Int Charges	584,934.70
Feb 1, 2024	IBRD-88300	Loan Repay	1,418,654.00
Feb 1, 2024	IBRD-88300	Int Charges	10.26
Feb 1, 2024	IBRD-88300	Int Charges	136.81
Aug 1, 2024	IBRD-88300	Int Charges	539,292.00
Aug 1, 2024	IBRD-88300	Loan Repay	1,415,504.10
Aug 1, 2024	IBRD-83380	Int Charges	359,350.40
Aug 1, 2024	IBRD-83380	Loan Repay	1,641,706.80
Mar 20, 2018	IBRD-88300	Loan Commitment	31,100,000.00
Feb 25, 2014	IBRD-83380	Loan Commitment	40,000,000.00
Aug 1, 2016	IBRD-83380	Int Charges	3,774.67
May 10, 2017	IBRD-83380	Loan Disb	91,064.69
Feb 21, 2017	IBRD-83380	Loan Disb	190,586.97
Nov 30, 2017	IBRD-83380	Loan Disb	387,869.80
Aug 25, 2017	IBRD-83380	Loan Disb	222,349.10
Sep 18, 2017	IBRD-83380	Loan Disb	462,483.56
Sep 18, 2017	IBRD-83380	Loan Disb	1,694,073.40
Aug 1, 2017	IBRD-83380	Int Charges	79.77
Aug 1, 2017	IBRD-83380	Int Charges	3,462.26
Apr 10, 2018	IBRD-83380	Loan Disb	945,572.06
Apr 10, 2018	IBRD-83380	Loan Disb	9,635,161.00
Feb 1, 2018	IBRD-83380	Int Charges	5,251.47
Feb 2, 2018	IBRD-83380	Loan Disb	2,236,951.00
Feb 21, 2018	IBRD-83380	Loan Disb	484,110.50
Mar 23, 2018	IBRD-83380	Loan Disb	660,091.00
Jul 24, 2018	IBRD-88300	Loan Disb	73,209.38
Jul 24, 2018	IBRD-88300	Fee Charges	73,209.38
Aug 1, 2018	IBRD-83380	Int Charges	14,304.04
May 31, 2018	IBRD-83380	Loan Disb	457,915.28
Jun 18, 2018	IBRD-83380	Loan Disb	778,032.44
May 30, 2018	IBRD-83380	Loan Disb	711,157.90
Sep 14, 2018	IBRD-83380	Loan Disb	2,348,009.50
Sep 5, 2018	IBRD-83380	Loan Disb	453,372.34
Jul 24, 2018	IBRD-83380	Loan Disb	661,630.20
Sep 5, 2018	IBRD-83380	Loan Disb	290,855.60
Dec 4, 2018	IBRD-83380	Loan Disb	675,849.40
Nov 29, 2018	IBRD-83380	Loan Disb	444,089.12
Dec 10, 2018	IBRD-83380	Loan Disb	325,534.28
Feb 1, 2019	IBRD-83380	Int Charges	194.86
Feb 1, 2019	IBRD-83380	Int Charges	25,879.02
Feb 1, 2019	IBRD-88300	Int Charges	14,331.08
Feb 1, 2019	IBRD-88300	Int Charges	4.62
Feb 1, 2019	IBRD-88300	Int Charges	36,041.72
Feb 1, 2019	IBRD-88300	Int Charges	113.56
Mar 19, 2019	IBRD-83380	Loan Disb	509,876.78
Mar 1, 2019	IBRD-88300	Loan Disb	2,276,800.00
Jul 11, 2019	IBRD-83380	Loan Disb	298,995.00
Aug 1, 2019	IBRD-88300	Int Charges	31,798.28
May 8, 2015	IBRD-83380	Loan Disb	81,578.21
May 8, 2015	IBRD-83380	Fee Charges	81,578.21
Jul 29, 2015	IBRD-83380	Loan Disb	2,211,100.00
Nov 20, 2015	IBRD-83380	Loan Disb	113,250.51
Feb 1, 2016	IBRD-83380	Int Charges	169.20
Feb 1, 2016	IBRD-83380	Int Charges	4,698.93
Feb 18, 2016	IBRD-83380	Loan Disb	155,935.38
Jun 1, 2016	IBRD-83380	Loan Disb	94,526.09
Aug 11, 2016	IBRD-83380	Loan Disb	127,593.14
Dec 7, 2016	IBRD-83380	Loan Disb	211,684.12
Feb 1, 2017	IBRD-83380	Int Charges	44.96
Feb 1, 2017	IBRD-83380	Int Charges	3,051.44

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Project Management	Satisfactory	2022-11-11
Procurement	Satisfactory	2022-11-11
Financial Management	Satisfactory	2022-11-11
Monitoring and Evaluation	Satisfactory	2022-11-11
Progress towards achievement of PDO	Moderately Satisfactory	2022-11-11
Overall Implementation Progress (IP)	Moderately Satisfactory	2022-11-11

COMPLETION RATINGS

INDICATOR	IMPLEMENTATION COMPLETION & RESULTS REPORT: 07-21-2023
Outcomes	Substantial
Risk to Development Outcome
Bank Performance	Substantial
Borrower Performance
Government Performance
Implementing Agency

INDEPENDENT EVALUATION RATINGS

INDICATOR	ICR REVIEW: 01-25-2024	PROJECT PERFORMANCE ASSESSMENT REPORT:
Outcome Rating	Satisfactory	N/a
Risk To Development Outcome		N/a
Bank Performance	Satisfactory	N/a
Borrower Performance		N/a
Government Performance		N/a
Implementing Agency		N/a
Icr Quality	Substantial	N/a
M&e Quality	Substantial	N/a

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Percentage of total acute care hospitalization cases in public hospitals reported accurately based on DRGs Value 0.00 95.00 0.00
Date October 16, 2013 December 31, 2022
Comment

Percent reduction in average unit price relative to baseline for the 50 most frequently dispensed multi-source pharmaceuticals thatare procured through centralized framework contracts	Value	0.00	27.00	27.00
	Date	October 16, 2013	December 31, 2022	December 31, 2022
	Comment

Percentage of patients starting radiotherapy treatment at public hospitals within 28 days between the date of issuance of treatmentprotocol and the first radiotherapy session for a) breast, b) cervic	Value	No monitoring system in place to report on the ind	Monitoring system in place to measure the indicato
	Date	October 16, 2013	December 31, 2022
	Comment

Percentage of registered adult patients in Dom Zdravljas with recorded blood pressure value, BMI, smoking status and recommended tips for healthy behavior in the preceding 12 months in their med recor	Value	35.00	45.00	35.00
	Date	October 16, 2013	December 31, 2022
	Comment

Percentage of registered insured persons covered by the targeted examination for early detection of a) breast (age 50-69 in the past two years), b) cervical (age 25-64 in the past three years) and c)	Value	a) 6%;b) 27%;c) 10%	a) 25%;b) 35%;c) 35%
	Date	November 30, 2017	December 31, 2022
	Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Percentage of pilot Dom Zdravljas who meet grant agreement performance criteria in the preceding one year Value 0.00 71.43 30.00
Date October 16, 2013 December 31, 2022 December 31, 2022
Comment
Number of pharmaceuticals and health products that are procured through centralized framework contracts Value 0.00 700.00 0.00
Date October 16, 2013 December 31, 2022
Comment
Number of clinical pathways developed Value 14.00 50.00 48.00
Date October 16, 2013 December 31, 2022 December 31, 2022
Comment
DRGs payment system developed and financing for a portion of acute hospital care based on DRGs initiated Value No Yes No
Date October 16, 2013 December 31, 2022
Comment

Percentage of a) Dom Zdravljas and b) pharmacies implementing e-prescription system	Value	DZs - 0Pharm - 0	DZs - 98%; Pharm - 98%	DZ - 90%; Pharm - 90%
	Date	October 16, 2013	December 31, 2022	December 31, 2022
	Comment

Number of health care institutions that have completed staff training on priority clinical pathways Value 50.00 289.00 160.00
Date October 16, 2013 December 31, 2022 December 31, 2022
Comment
Number of health workers receiving training Value 500.00 39479.00 13000.00
Date January 16, 2014 December 31, 2022 December 31, 2022
Comment
Reduction in the total consumption of antibiotics for systemic use (J01) DDD/1000 person/per day Value 0.00 22.00 0.00
Date November 30, 2017 December 31, 2022
Comment

Ranking of health institutions according to quality criteria in place based on quality indicators in health care	Value	Existing quality indicators	Ranking of health institutions according to qualit	Existing quality indicators/No
	Date	January 16, 2014	December 31, 2022
	Comment

Strengthen systems for Health Technology Assessment	Value	Limited institutional efficiency related to the de	The linkage between national clinical guidelines a
	Date	November 30, 2017	December 31, 2022
	Comment

Number of new linear accelerators installed at national level Value 0.00 12.00 12.00
Date October 16, 2013 December 31, 2022 December 31, 2022
Comment

Strengthen systems for medical equipment maintenance	Value	No national systems or policies in place, Medical	Budget allocated to expand maintenance system. Nat	No national systems or policies in place. Medical
	Date	January 16, 2014	December 31, 2022
	Comment

Percentage of adult diabetic patients in Dom Zdravljas with at least one determined value of glycosylated hemoglobin (HbA1c) in thelast year	Value	45.00	38.50	50.00
	Date	October 16, 2013	December 31, 2022	December 31, 2022
	Comment

Annual training organized for health Roma mediators Value 0.00 4.00 0.00
Date November 30, 2017 December 31, 2022
Comment

Percentage of registered adult patients in DZs with hypertension under treatment whom in the last recorded blood pressure (measuredin the preceding one year) is = 140/90 mm Hg	Value	45.00	44.10	70.00
	Date	January 16, 2014	December 31, 2022	December 31, 2022
	Comment

Percentage of patients satisfied with the quality of care in PHC facilities (CE) Value 78.00 80.00 0.00
Date November 30, 2017 December 31, 2022
Comment

Number of clinical pathways developed	Value	14.00	50.00	48.00
	Date	October 16, 2013	December 31, 2022	December 31, 2022
	Comment

Number of health workers receiving training	Value	500.00	39479.00	13000.00
	Date	January 16, 2014	December 31, 2022	December 31, 2022
	Comment

Percentage of patients satisfied with the quality of care in PHC facilities (CE)	Value	78.00	80.00	0.00
	Date	November 30, 2017	December 31, 2022
	Comment